Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients.
Pavelka K, Szekanecz Z, Damjanov N, Anić B, Tomšič M, Mazurov V, Maksimovic M, Nagy O, Świerkot J, Petranova T, Veldi T, Baranauskaitė A, Codreanu C, Andersone D, Fleischmann R. Pavelka K, et al. Among authors: swierkot j. Drugs Context. 2020 Oct 19;9:2020-7-5. doi: 10.7573/dic.2020-7-5. eCollection 2020. Drugs Context. 2020. PMID: 33123205 Free PMC article.
Rheumatoid arthritis - medication dosage in chronic kidney disease.
Tyczyńska KM, Augustyniak-Bartosik H, Świerkot J. Tyczyńska KM, et al. Among authors: swierkot j. Reumatologia. 2023;61(6):481-491. doi: 10.5114/reum/177005. Epub 2024 Jan 18. Reumatologia. 2023. PMID: 38322106 Free PMC article. Review.
Monitoring methotrexate therapy in patients with rheumatoid arthritis.
Wiela-Hojenska A, Orzechowska-Juzwenko K, Swierkot J, Wiland P, Hurkacz M, Szechinski J. Wiela-Hojenska A, et al. Among authors: swierkot j. Int J Clin Pharmacol Ther. 2004 Aug;42(8):434-41. doi: 10.5414/cpp42434. Int J Clin Pharmacol Ther. 2004. PMID: 15366323
Methotrexate in rheumatoid arthritis.
Swierkot J, Szechiński J. Swierkot J, et al. Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Pharmacol Rep. 2006. PMID: 16963793 Free article. Review.
The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis.
Świerkot J, Nowak B, Czarny A, Zaczyńska E, Sokolik R, Madej M, Korman L, Sebastian A, Wojtala P, Lubiński Ł, Wiland P. Świerkot J, et al. Adv Clin Exp Med. 2016 Jul-Aug;25(4):709-17. doi: 10.17219/acem/61034. Adv Clin Exp Med. 2016. PMID: 27629845 Free article.
Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.
López-Rodríguez R, Ferreiro-Iglesias A, Lima A, Bernardes M, Pawlik A, Paradowska-Gorycka A, Świerkot J, Slezak R, Dolžan V, González-Álvaro I, Narváez J, Cáliz R, Pérez-Pampín E, Mera-Varela A, Vidal-Bralo L, Acuña Ochoa JG, Conde C, Gómez-Reino JJ, González A. López-Rodríguez R, et al. Among authors: swierkot j. Sci Rep. 2018 May 9;8(1):7342. doi: 10.1038/s41598-018-25634-y. Sci Rep. 2018. PMID: 29743634 Free PMC article.
82 results